tada or anyone,..

If they could get a $12 billion push in market cap cause their Phase 2 showed promise for Alzheimer's drug,... what would we get for a promising report for CD for a sub-group study,...

What are the differences between a Phase 2 and a sub group of a phase 3,..?

Will investors make the connection between CD and Alzheimer's,...?

We are a Canadian company not on the Nasdaq,,....?

Would we get at least a $5 billion increase in market share,... anyone up to doing a comparision between the two,... results of there phase 2 (which later failed their phase 3) and our sub-group study,..?